(Q43821531)

27 November 2017

Synthesis and cytotoxic activity of tetracenomycin D and of saintopin analogues (English)

1 reference

27 November 2017

Philippe Martin

1

1 reference

27 November 2017

Stéphane Rodier

2

1 reference

27 November 2017

Martine Mondon

3

1 reference

27 November 2017

Brigitte Renoux

4

1 reference

27 November 2017

Bruno Pfeiffer

5

1 reference

27 November 2017

Pierre Renard

6

1 reference

27 November 2017

Alain Pierré

7

1 reference

27 November 2017

Jean Pierre Gesson

8

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 February 2002

1 reference

Bioorganic & Medicinal Chemistry

27 November 2017

1 reference

27 November 2017

10

1 reference

27 November 2017

2

1 reference

27 November 2017

253-260

1 reference

Saintopin, a new antitumor antibiotic with topoisomerase II dependent DNA cleavage activity, from Paecilomyces

27 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900273-5

7 January 2021

Correlation between the formation of cleavable complex with topoisomerase I and growth-inhibitory activity for saintopin-type antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900273-5

7 January 2021

UCE1022, a new antitumor antibiotic with topoisomerase I mediated DNA cleavage activity, from Paecilomyces

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900273-5

7 January 2021

UCE6, a new antitumor antibiotic with topoisomerase I mediated DNA cleavage activity, from actinomycetes

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900273-5

7 January 2021

Induction of mammalian DNA topoisomerase I and II mediated DNA cleavage by saintopin, a new antitumor agent from fungus

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900273-5

7 January 2021

Comparative studies of antitumor DNA intercalating agents, aclacinomycin and saintopin, by means of surface-enhanced Raman scattering spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900273-5

7 January 2021

Topoisomerase inhibitors. A review of their therapeutic potential in cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900273-5

7 January 2021

Topoisomerase I inhibitors: topotecan and irenotecan

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900273-5

7 January 2021

Metabolic products of microorganisms. 175. Tetracenomycin C (author's transl)

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900273-5

7 January 2021

Anthracycline metabolites of tetracenomycin C-nonproducing Streptomyces glaucescens mutants

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900273-5

7 January 2021

Isolation of tetracenomycin C-nonproducing Streptomyces glaucescens mutants

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900273-5

7 January 2021

Metabolic products of microorganisms. 249. Tetracenomycins B3 and D3, key intermediates of the elloramycin and tetracenomycin C biosynthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900273-5

7 January 2021

Regiospecific syntheses of quinones using vinylketene acetals derived from unsaturated esters

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900273-5

7 January 2021

Novel selective inhibitors for human topoisomerase I, BM2419-1 and -2 derived from saintopin

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900273-5

7 January 2021

In vitro cytotoxicity of S16020-2, a new olivacine derivative

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900273-5

7 January 2021

10.1016/S0968-0896(01)00273-5

Identifiers

DOI

1 reference

27 November 2017

1 reference